GSTC
GLOBESTAR THERAPEUTICS CO by GlobeStar Therapeutics Corporation (GSTC)
$00
About GLOBESTAR THERAPEUTICS CO by GlobeStar Therapeutics Corporation (GSTC)
GlobeStar Therapeutics Corp. is a clinical stage biotechnology company, which engages in the manufacture and patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company was founded by David P. Summers in 2011 and is headquartered in Richland, WA.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
248,200
Dividend yield
0.00%
Volume
--
Avg. volume
2.1M
P/E ratio
-.22
GLOBESTAR THERAPEUTICS CO by GlobeStar Therapeutics Corporation News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
248,200
Dividend yield
0.00%
Volume
--
Avg. volume
2.1M
P/E ratio
-.22